Senior Biostatistician, Clinical Trials β€” UK

Senior Biostatistician, Clinical Trials β€” UK

Full-Time 59400 - 72600 Β£ / year (est.) No working from home possible
Syneos Health

At a Glance

  • Tasks: Support drug development and commercialisation through statistical programming and regulatory insights.
  • Company: Join Syneos Health, a leader in clinical solutions across EMEA.
  • Benefits: Competitive salary, professional growth, and a chance to impact healthcare.
  • Other info: Dynamic team environment with opportunities for career advancement.
  • Why this job: Make a difference in drug development while working with top professionals in the field.
  • Qualifications: Master's in Biostatistics and 5+ years in clinical research, with R and RShiny expertise.

The predicted salary is between 59400 - 72600 Β£ per year.

Syneos Health is seeking a Principal Biostatistician to join our Clinical Solutions team in the United Kingdom.

The role focuses on supporting drug development and commercialization efforts across the EMEA region, with emphasis on statistical programming and regulatory considerations.

The ideal candidate has a Master's degree or higher in Biostatistics and at least 5 years of experience in a clinical research setting, with strong skills in R and RShiny.

#J-18808-Ljbffr

Senior Biostatistician, Clinical Trials β€” UK employer: Syneos Health

At Syneos Health, we pride ourselves on being an exceptional employer, offering a dynamic work culture that fosters collaboration and innovation. As a Pharmacy Sales Representative in Bristol, you'll benefit from comprehensive training, ongoing professional development opportunities, and the chance to make a meaningful impact in the healthcare sector. Our commitment to diversity and inclusion ensures that every employee feels valued and empowered to succeed.

Syneos Health

Contact Details:

Syneos Health Recruitment Team

We think you need these skills to ace Senior Biostatistician, Clinical Trials β€” UK

Biostatistics
Statistical Programming
R
RShiny
Clinical Research
Regulatory Considerations
Drug Development